KPIs & Operating Metrics(New)
Growth Metrics

Stryker (SYK) Shares Outstanding (Weighted Average) (2009 - 2026)

Stryker (SYK) reported Shares Outstanding (Weighted Average) of $382.9 million for Q1 2026, little changed year-over-year from $381.7 million in Q1 2025, and little changed on a QoQ basis from $382.2 million in Q4 2025.

Stryker (SYK) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $382.9 million in Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.31% year-over-year to $382.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $382.9 million (changed 0.31% YoY) and the FY2025 annual result came in at $382.2 million, changed 0.31% from the prior year.
  • Shares Outstanding (Weighted Average) was little changed at $382.9 million in Q1 2026 per SYK's latest filing, from $382.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $382.9 million in Q1 2026 and bottomed at $377.7 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $380.4 million (2024), against an average of $380.3 million.
  • Peak annual rise in Shares Outstanding (Weighted Average) reached 0.45% in 2023, while the deepest fall reached 0.29% in 2023.
  • Tracing SYK's Shares Outstanding (Weighted Average) over 5 years: stood at $378.2 million in 2022, then gained by 0.37% to $379.6 million in 2023, then climbed by 0.37% to $381.0 million in 2024, then rose by 0.31% to $382.2 million in 2025, then climbed by 0.18% to $382.9 million in 2026.
  • Per Business Quant, the three latest SYK Shares Outstanding (Weighted Average) figures stand at $382.9 million (Q1 2026), $382.2 million (Q4 2025), and $382.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 195.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 382.90 Mn
Dec 31, 2025 382.20 Mn
Sep 30, 2025 382.40 Mn
Jun 30, 2025 382.20 Mn
Mar 31, 2025 381.70 Mn
Dec 31, 2024 381.00 Mn
Sep 30, 2024 381.10 Mn
Jun 30, 2024 381.00 Mn
Mar 31, 2024 380.40 Mn
Dec 31, 2023 379.60 Mn
Sep 30, 2023 379.80 Mn
Jun 30, 2023 379.40 Mn
Mar 31, 2023 379.00 Mn
Dec 31, 2022 378.20 Mn
Sep 30, 2022 378.10 Mn
Jun 30, 2022 378.30 Mn
Mar 31, 2022 377.70 Mn
Dec 31, 2021 377.00 Mn
Sep 30, 2021 376.80 Mn
Jun 30, 2021 376.90 Mn
Mar 31, 2021 376.30 Mn
Dec 31, 2020 375.50 Mn
Sep 30, 2020 375.30 Mn
Jun 30, 2020 375.50 Mn
Mar 31, 2020 374.80 Mn
Dec 31, 2019 374.00 Mn
Sep 30, 2019 373.80 Mn
Jun 30, 2019 373.90 Mn
Mar 31, 2019 373.30 Mn
Dec 31, 2018 374.10 Mn
Sep 30, 2018 374.00 Mn
Jun 30, 2018 373.90 Mn
Mar 31, 2018 374.00 Mn
Dec 31, 2017 374.00 Mn
Sep 30, 2017 374.20 Mn
Jun 30, 2017 373.90 Mn
Mar 31, 2017 373.40 Mn
Dec 31, 2016 374.10 Mn
Sep 30, 2016 374.40 Mn
Jun 30, 2016 374.20 Mn
Mar 31, 2016 373.20 Mn
Dec 31, 2015 376.60 Mn
Sep 30, 2015 376.30 Mn
Jun 30, 2015 377.00 Mn
Mar 31, 2015 378.90 Mn
Dec 31, 2014 378.50 Mn
Sep 30, 2014 378.50 Mn
Jun 30, 2014 378.50 Mn
Mar 31, 2014 378.20 Mn
Dec 31, 2013 378.60 Mn
Sep 30, 2013 378.30 Mn
Jun 30, 2013 378.00 Mn
Mar 31, 2013 379.70 Mn
Dec 31, 2012 380.60 Mn
Sep 30, 2012 380.70 Mn
Jun 30, 2012 381.00 Mn
Mar 31, 2012 381.00 Mn
Dec 31, 2011 386.50 Mn
Sep 30, 2011 388.10 Mn
Jun 30, 2011 389.10 Mn
Mar 31, 2011 390.00 Mn
Dec 31, 2010 396.40 Mn
Sep 30, 2010 397.00 Mn
Jun 30, 2010 397.00 Mn
Mar 31, 2010 397.20 Mn
Dec 31, 2009 397.40 Mn
Sep 30, 2009 397.60 Mn
Jun 30, 2009 397.40 Mn
Mar 31, 2009 396.70 Mn